PSG-specific <i>Fzr</i> mutation decreases the expression of silk protein genes. by Wenliang Qian (639395)

“…Scale bar, 1cm. WT, wild type. L5D3, the third day of the fifth larval instar; L5D5, the fifth day of the fifth larval instar; W0, just wandering.…”

A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

“…Sequences used were obtained from GenBank at NCBI (human, <i>Homo sapiens</i>, NP_076425.1; chimp, <i>Pan troglodytes</i>, XP_001160122.1; monkey, <i>Macaca mulatta</i>, NP_001244544.1; mouse, <i>Mus musculus</i>, NP_081622.1; rat, <i>Rattus norvegicus</i>, NP_001099241.1; cow, <i>Bos taurus</i>, NP_001192540.1; dog, <i>Canis lupus familiaris</i>, XP_003639160.1; chicken, <i>Gallus gallus</i>, NP_001264526.1; frog, <i>Xenopus tropicalis</i>, NP_001004910.2; zebrafish, <i>Danio rerio</i>, NP_001007377.2) and the alignment was produced using ClustalW2 [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005089#pgen.1005089.ref041" target="_blank">41</a>]. …”

Ppk1 levels are not affected by decreasing dendrite arbor size but are reduced when dendrite length increases. by Josephine W. Mitchell (17364781)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Subjects:

Cooperativity decreases with the expression level of CheA. by Stephan Eismann (835052)

Decreased biomechanical stability of bones from <i>Col1a1-Krm2</i> transgenic mice. by Jochen Schulze (365258)

“…(D) Cortical thickness (C.Th.) and bone mineral density (vBMD) are decreased in <i>Col1a1-Krm2</i> transgenic mice compared to wildtype littermates. …”

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Subjects:

Mutation of Ser-473 in GC-A to alanine but not glutamate decreases ANP-stimulated guanylyl cyclase activity. by Andrea R. Yoder (165684)

Removal of the A-B linker did not decrease PIP₂ affinity. <i>A.-</i> by Paloma Aivar (124885)

Endoplasmic reticulum calcium decrease via RyR in response to HIV-1 Tat. by John P. Norman (269281)

Promoter Hypermethylation and Decreased Expression of Syncytin-1 in Pancreatic Adenocarcinomas by Qinsheng Lu (778233)

Resveratrol decreased tumor latency in <i>Sirt1^Y/+</i> mice. by Katherine V. Clark-Knowles (368164)

Decreased expression of V-ATPase upon the siRNA transfection. by Manisha Naskar (2613763)

Decreased expression of ATG5 upon the siRNA transfection. by Manisha Naskar (2613763)

Early increase and later decrease in GSK-3β activity. by Arie J. Hoogendijk (353624)

Expression of vTR harboring the mutant template (AU5) decreases cell proliferation of an avian cancer cell line. by Benedikt B. Kaufer (341018)

Knockdown of <i>CPT1A</i> inactivates most of fatty acid oxidation (FAO) and decreases cellular proliferation. by Cong-Hui Yao (2013793)

“…(C) The decrease in cellular proliferation cannot be rescued by various concentrations of acetate (<i>n</i> = 5). …”